Singapore's SGI announces JV to expedite financing for clinical trials
This alliance is set to broaden SGI's TrialCap platform, which provides specialised funding solutions for clinical trials ranging from Phase I through Phase III.
TrialCap's two decades of industry 'expertise' is set to offer flexible and financial backing to medtech and biotech firms. This is expected to assist these companies in progressing their therapies and bringing treatments to market sooner.
SGI managing partner and co-founder Michael Shleifer said: 'Our mission is to remove financial barriers that hinder biotech and medtech companies from focusing on research and development.
'Through this strategic partnership with OneIM, we are significantly expanding our ability to provide critical financing solutions that drive innovation in life sciences.'
SGI, established in 2008, is a private investment firm with a focus on clinical-stage life sciences and pharmaceutical services.
Its investment model is designed to offer 'agile' financing to biotech companies globally, thereby backing the trial progression and the development of transformative treatments.
OneIM is an alternative investment manager that invests across various asset classes and industries and its team operates from offices in London, Abu Dhabi, Tokyo and New York.
Founded in 2022, it manages assets worth approximately $7bn.
OneIM partner Matt Ross said: 'We see tremendous opportunities in the life sciences sector and are delighted to collaborate with SGI, a firm that has a proven track record, deep connectivity across the healthcare ecosystem, and a strong pipeline of opportunities.
'We look forward to accelerating the growth of this platform alongside Michael and the team.'
"Singapore's SGI announces JV to expedite financing for clinical trials" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Farewell to a soy sauce chicken legend – Ma Li Ya Virgin Chicken closes for good
It's official — Ma Li Ya Virgin Chicken, a beloved name in Singapore's hawker scene, has quietly shuttered at Chinatown Complex Food Centre. Though the exact closing date remains unclear, it's understood that the stall ceased operations in early Aug 2025. To loyal patrons, I'd imagine this feels like saying goodbye to a dear friend, one who fed both stomachs and souls. Founded by Xiao Peiying, affectionately known by her English name 'Maria', Ma Li Ya Virgin Chicken has drawn generations of fans for its silky, soy sauce chicken and comforting plates of braised tofu and rice. They first launched in 1989, then relaunched in 2011 after a hiatus, carving out a reputation for honest, soulful food rooted in tradition and her father's recipe from way back in 1926! Talks of their closure date back to Jan 2025, when Maria announced her plans to retire at 75, citing old age and slow business as key reasons. Since then, she had been searching for a worthy successor to carry on her legacy. Despite receiving a jaw-dropping S$500,000 offer, Maria stood firm — she wasn't looking for just any buyer, she was looking for someone who genuinely wanted to preserve the legacy she had built. She even listed her treasured recipe for S$138,000, offering to personally train the right person to take over. But as time passed and no buyer came forward, the inevitable happened. On 6 Aug, a regular customer shared a farewell tribute with a picture of the shuttered storefront on Facebook with the caption, 'It is slowly sinking in. Maria had been talking about hanging up her apron for a year and it has finally happened.' The bittersweet tone echoed what many longtime customers must be feeling — a surge of gratitude tinged with loss. In the end, Ma Li Ya didn't just serve soy sauce chicken. They served heart, heritage, and a reminder that some flavours, and the people behind them, can never be replaced. Thank you for your years of service, Maria. Soya Chicken Showdown: Chiew Kee Eating House vs Chew Kee Eating House The post Farewell to a soy sauce chicken legend – Ma Li Ya Virgin Chicken closes for good appeared first on
Time Business News
19 minutes ago
- Time Business News
Tawny Swift Ltd. Achieves Landmark $500,000 Recovery for Ohio Nurse from Fake Crypto Investment Platform Hoea-Forex
NEW YORK, NY – August 1, 2025 – Tawny Swift Ltd., a leading cryptocurrency recovery firm renowned for its innovative application of Artificial Intelligence (AI) and blockchain forensics, today announced the successful recovery of $500,000 for an Ohio-based nurse who fell victim to a sophisticated fake crypto investment platform known as Hoea-Forex. This significant achievement underscores the firm's unparalleled capability in combating advanced digital asset fraud. The victim, who wishes to remain anonymous, had invested her life savings into Hoea-Forex, believing it to be a legitimate and high-yield cryptocurrency trading platform. Lured by consistent initial 'returns' displayed on a seemingly authentic interface, she continued to invest more funds, only for the platform to abruptly cease all communication and withdrawal functionalities, a hallmark of 'pig butchering' scams. Devastated and facing severe financial hardship, she sought assistance from Tawny Swift Ltd. Upon engagement, Tawny Swift Ltd.'s specialized team immediately deployed its cutting-edge AI- driven analytics and deep blockchain expertise. The firm's proprietary technology was instrumental in meticulously tracing the complex flow of the stolen funds across multiple blockchain networks and identifying the hidden wallets associated with the fraudulent entity. This intricate digital forensic work allowed Tawny Swift Ltd. to pinpoint recoverable assets and execute the successful retrieval. David Braxton, CEO of Tawny Swift Ltd., commented on the pivotal recovery: ' This case represents a benchmark standard for what is achievable in the challenging landscape of cryptocurrency recovery. Our success here is a testament to the unparalleled integration of AI and blockchain expertise within our firm. We understand the devastating impact these scams have on individuals, and we are dedicated to leveraging cutting-edge technology to fight back and restore what was lost .' The incident serves as a stark reminder of the escalating threat posed by sophisticated crypto investment scams globally. Scammers are becoming increasingly cunning, exploiting the allure of high returns and the technical complexity of digital assets to defraud unsuspecting investors. Tawny Swift Ltd. emphasizes the critical importance of due diligence and urges potential investors to thoroughly vet any platform before committing funds, advising caution against offers that seem 'too good to be true.' This successful recovery not only provides vital financial restitution for the Ohio nurse but also offers a beacon of hope for countless other victims grappling with similar losses. Tawny Swift Ltd. remains committed to leading the charge against crypto fraud, continually refining its methodologies to stay ahead of malicious actors and protect the integrity of the digital asset ecosystem. About Tawny Swift Ltd. Tawny Swift Ltd. is a premier cryptocurrency recovery firm specializing in the tracing, freezing, and recovery of fraudulently obtained, lost or stolen cryptocurrency assets. Leveraging a unique blend of artificial intelligence, blockchain analytics, and forensic expertise, Tawny Swift Ltd. assists individuals and organizations worldwide in navigating the complex landscape of crypto fraud, offering hope and tangible solutions for victims. The firm is dedicated to setting new benchmarks in digital asset security and recovery. Organization: Tawny Swift Ltd Contact Person: Peter Lim Website: Email: contact@ TIME BUSINESS NEWS
Business Insider
31 minutes ago
- Business Insider
Nvidia Stock (NVDA) Closes at Record High
Shares of Nvidia (NVDA) finished the trading week on Aug. 8 at an all-time high as investors continue to push the artificial intelligence (AI) trade to new heights. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. NVDA stock closed at $182.70, which is a record high on a split-adjusted basis. The chipmaker's stock has now risen 36% this year and hit 19 all-time highs in the process. The latest peak comes on optimism related to a new AI model from OpenAI and the potential for increased spending by Tesla (TSLA), both of which should positively impact Nvidia's sales. Nvidia's shares have now increased nearly 75% over the last 12 weeks, giving the company a market capitalization of $4.46 trillion and making it the most valuable publicly traded company in the world. Tariffs NVDA stock also got a boost this week when it was announced that there are widespread exemptions from U.S. President Donald Trump's proposed 100% tariff on microchip imports for companies such as Nvidia. The Silicon Valley-based chipmaker announced this spring that it plans to develop up to $500 billion in AI infrastructure in the U.S. over the next four years. News that privately held OpenAI launched GPT-5, its latest chatbot, is seen as good news for Nvidia's chip sales. OpenAI CEO Sam Altman recently named Nvidia a key partner. Additionally, Nvidia could receive more cash from Tesla, which is downsizing its internal microchip lineup and disbanding its supercomputer team. Tesla is expected to rely more on hardware and microchips from Nvidia moving forward. Is NVDA Stock a Buy? The stock of Nvidia has a consensus Strong Buy rating among 38 Wall Street analysts. That rating is based on 34 Buy, three Hold, and one Sell recommendations issued in the past three months. The average NVDA price target of $186.24 implies 1.94% upside from current levels.
